Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,042 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor.
Harada H, Asano O, Hoshino Y, Yoshikawa S, Matsukura M, Kabasawa Y, Niijima J, Kotake Y, Watanabe N, Kawata T, Inoue T, Horizoe T, Yasuda N, Minami H, Nagata K, Murakami M, Nagaoka J, Kobayashi S, Tanaka I, Abe S. Harada H, et al. Among authors: yoshikawa s. J Med Chem. 2001 Jan 18;44(2):170-9. doi: 10.1021/jm990499b. J Med Chem. 2001. PMID: 11170626
E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo[4,5-d]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor.
Yasuda N, Nagakura T, Inoue T, Yamazaki K, Katsutani N, Takenaka O, Clark R, Matsuura F, Emori E, Yoshikawa S, Kira K, Ikuta H, Okada T, Saeki T, Asano O, Tanaka I. Yasuda N, et al. Among authors: yoshikawa s. Eur J Pharmacol. 2006 Oct 24;548(1-3):181-7. doi: 10.1016/j.ejphar.2006.08.011. Epub 2006 Aug 16. Eur J Pharmacol. 2006. PMID: 16973152
Comprehension of gut microbiota and microRNAs may contribute to the development of innovative treatment tactics against metabolic disorders and psychiatric disorders.
Nakashima M, Suga N, Fukumoto A, Yoshikawa S, Matsuda S. Nakashima M, et al. Among authors: yoshikawa s. Int J Physiol Pathophysiol Pharmacol. 2024 Dec 25;16(6):111-125. doi: 10.62347/WAZH2090. eCollection 2024. Int J Physiol Pathophysiol Pharmacol. 2024. PMID: 39850247 Free PMC article. Review.
Dissolution of struvite stones with ascorbic acid.
Yoshikawa S. Yoshikawa S. Urol Case Rep. 2024 Dec 10;58:102906. doi: 10.1016/j.eucr.2024.102906. eCollection 2025 Jan. Urol Case Rep. 2024. PMID: 39759588 Free PMC article.
1,042 results